Exponent price to free cash flow EXPO
Market value divided by free cash flow over the last twelve months, since 2012.
- Today, Oct 23, 2026
- 33.9×
- 10-year median
- 38.9×
- Against its 10-year history
- 32nd
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 23.0× to 65.5×
- Peer median
- 15.7×
Exponent's price to free cash flow is 33.9× as of Oct 23, 2026.
That is below its ten-year median of 38.9×, lower than on 68% of days in the last ten years.
Over that time it ranged from 23.0× in May 2026 to 65.5× in Jun 2023.
The median for 8 consulting Services stocks of a similar size is 15.7×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 33.9× | 23.0× | 33.9× |
| 2025 | 29.0× | 25.8× | 31.6× |
| 2024 | 29.6× | 29.6× | 58.6× |
| 2023 | 56.2× | 42.7× | 65.5× |
| 2022 | 51.8× | 38.6× | 55.9× |
| 2021 | 54.9× | 39.5× | 55.5× |
| 2020 | 43.0× | 34.4× | 55.7× |
| 2019 | 47.7× | 35.3× | 59.0× |
| 2018 | 35.0× | 31.3× | 42.1× |
| 2017 | 35.3× | 28.3× | 37.2× |
| 2016 | 31.3× | 22.3× | 33.5× |
| 2015 | 25.2× | 21.5× | 28.8× |
| 2014 | n/m a value too high to mean anything | ||
| 2013 | 25.1× | 15.3× | 26.7× |
| 2012 | 18.6× | 13.8× | 18.6× |
Against its peers
Companies in Consulting Services nearest Exponent's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| EXPOExponent | 33.9× |
| FCNFTI Consulting | 12.1× |
| HURNHuron Consulting | 19.3× |
| ASTHAstrana Health | 22.1× |
| GGenpact LTD | 12.0× |
| ICFIICF International | 8.5× |
| BAHBooz Allen Hamilton | 8.4× |
| BWMNBowman Consulting | 59.1× |
| EFXEquifax | 19.4× |
| Peer median | 15.7× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Exponent
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.